Plaque and FFRCT together offer a better understanding of patient risk.1
Plaque assessment is highly correlated to IVUS for quantified plaque volumes for each vessel and lesion.2
Specific plaque characteristics, such as low attenuation plaque, have proven to correlate with higher risk.3
HeartFlow’s NEW Plaque analysis provides data on the type of plaque present (Calcified, Non-calcified, Low-Attenuation)4 which can provide detailed information for physicians to understand patient risk, discuss heart health, and inform optimal medical treatment options.
Using a large international cohort, HeartFlow analyzed over 11,000 CCTAs to stratify total coronary atherosclerotic plaque volumes by age and sex.5 Physicians can utilize this data to help aid in optimizing patient management.
HeartFlow’s AI-based plaque from CCTA was shown to be as accurate compared to IVUS, the gold standard, showing a total plaque volume (TPV) correlation coefficient of 0.92 and a correlation coefficient of >0.90 to expert CT readers.2,4
Non-invasive cardiac test that provides personalized physiology information, delivering better per vessel diagnostic performance.3
The RoadMap analysis enables CT readers to identify stenoses in coronary arteries to support clinicians’ evaluation of CCTAs.
REFERENCES
173938284 v1